Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Oct-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for ProPhase Labs Inc have a median target of 18.50, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate represents a 2,384.89% increase from the last price of 0.7445.
High | 2,720.7% | 21.00 |
Med | 2,384.9% | 18.50 |
Low | 2,049.1% | 16.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 13, 2025.
Average growth rate | -90.30% |
Average growth rate | +32.74% |
More ▼
Revenue history & estimates in USD
Average growth rate | -17.31% |
Average growth rate | +102.47% |
More ▼